---
canonical_url: https://www.stockexpertai.com/earnings/wab
last_updated: 2026-05-05T22:00:24.489Z
---

# Westinghouse Air Brake Technologies Corporation (WAB) Q4 FY2026 Earnings Preview

> This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-05T22:00:24.197Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $263.44 (▲ 0.47%) | fmp:quote |
| Market Cap | $44.7B | fmp:profile |
| 52w range | $184.26 – $275.84 | fmp:quote |
| Earnings | Thu 23 Jul | fmp:earnings-history |
| EPS estimate | $2.63 (+34% YoY) | fmp:earnings-estimate |
| Revenue estimate | $3.1B | fmp:earnings-estimate |
| Beat streak | 3/4 | fmp:earnings-history |
| Rating | B+ (overall 3/5) | fmp:ratings |
| Analyst median target | $304 (+15.4% upside) | fmp:price-target-consensus |
| MoonshotScore | 56/100 | derived |
| Council | 3/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## Westinghouse Air Brake Technologies Corporation — Q4 FY2026 Expectations

Q4 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$3.1B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$2.63</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 3 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** B+ · **Stance:** BUY · **Council:** 3/6 · **Moonshot:** 56

= MoonshotScore <strong>56</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>3/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (4 metrics)

### 1. Transit Segment Growth

Wabtec's Transit segment sales were up 17.8% to $835 million, with the acquisition of Dellner contributing to this growth.

> "Transit segment sales were up 17.8% at $835 million. When adjusting for foreign currency Transit sales were up 11.0%. The acquisition of Dellner added a partial quarter of revenue, adding approximately 5.8 percentage points of sales growth."
> — John Olin, Investor Focus · Q1 FY2026

### 2. Multiyear Backlog Growth

Wabtec's multiyear backlog exceeded $30 billion, up 38%, providing strong visibility as the company executes against its strategy.

> "Backlog remains a key strength. 12-month backlog was up 13% from the prior year, while the multiyear backlog exceeded $30 billion, up 38%."
> — Rafael Santana, Investor Focus · Q1 FY2026

### 3. Freight Segment Backlog

Wabtec's Freight segment's 12-month backlog was up 10.1%, while the multiyear backlog of $25.18 billion was up 41.0%.

> "Finally, the Freight segment's 12-month backlog was $6.68 billion. Our 12-month backlog was up 10.1%, while the multiyear backlog of $25.18 billion was up 41.0%."
> — John Olin, Investor Focus · Q1 FY2026

### 4. 2026 Railcar Demand

Wabtec notes that demand for new railcars in North America is expected to be approximately 24,000 cars for 2026, which is down 22% from 2025.

> "Looking at the North American railcar build, demand for new railcars is down compared to the prior year and is projected to be approximately 24,000 cars for 2026, which is down 22% from 2025."
> — Rafael Santana, Investor Focus · Q1 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 5.0 | medium | Q1 vs Q2: healthy growth (+9.0%) |
| Gross Margin | 4.0 | medium | Q1: average margin (36.0%) |
| Operating Leverage | 2.0 | weak | op margin healthy (17.5%) |
| Cash Runway | 10.0 | strong | FCF very strong ($0.2B, 3.3× CapEx) |
| R&D Intensity | 3.0 | weak | low R&D investment (2.0%, weak innovation) |
| Price Momentum | 7.0 | strong | RSI 52.9 balanced, 50d above |
| News Sentiment | 8.0 | strong | strong buy consensus (82%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +15.4% |
| Ken Griffin | bull | flow · 50d MA above |
| Jim Simons | neutral | quant · RSI 53 |
| Klarman | neutral | value · target upside +15.4% |
| Buffett | bull | quality · ROE score 4/5 |
| Munger | neutral | valuation · target upside +15.4% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Moderate
- **Margin of Safety:** Moderate
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 52.9 — dengeli — yön sinyali zayıf
- **50d MA:** $255 — hisse %3.2 üstünde — kısa vadeli destek
- **200d MA:** $220 — hisse %19.5 üstünde — uzun vadeli destek
- **Volume (10d):** -29%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q2 FY25 | $1.96 | $2.17 | MISS | -1.7% |
| Q3 FY25 | $2.32 | $2.28 | BEAT | +1.8% |
| Q4 FY25 | $2.10 | $2.08 | BEAT | -0.2% |
| Q1 FY26 | $2.71 | $2.51 | +8.0% EPS | +3.0% |

Q1 (April 22, 2026): EPS $2.71 vs $2.51 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +8.0% beat. D+1 movement: +3.0%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q4 EPS > $2.63 + CapEx discipline**

Threshold: EPS > $2.63<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $304<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $318<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $2.63 + CapEx < $46.0M**

Threshold: EPS ≈ $2.63<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q4 CapEx < $46.0M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $263<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $304<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $2.55 or CapEx ≥ $46.0M**

Threshold: EPS < $2.55<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $263 below SMA200 $220<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $187<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q1: EPS $2.71 vs $2.51 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock +3.0% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26

### CapEx shock
Q1 CapEx $46.0M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q1 op margin 17.5%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q4 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $304 (+15.4% upside vs current $263)
- **High / Low:** $318 / $221
- **Buy / Hold / Sell:** 9 / 2 / 0
- **Analyst count:** 7 (last quarter), 25 all-time

## Additional Transcript Insights

### 1. eps_guidance_increase

**Claim:** Wabtec is increasing its adjusted EPS guidance due to strong operational results and nonoperational favorability from currency fluctuations and taxes.

**Evidence (transcript):** "Overall, the team delivered a strong first quarter with operational results ahead of our expectations. EPS also benefited from nonoperational favorability driven by currency fluctuations and taxes."

**Numbers:** —

### 2. multiyear_backlog_growth

**Claim:** Wabtec's multiyear backlog exceeded $30 billion, up 38%, providing strong visibility as the company executes against its strategy.

**Evidence (transcript):** "Backlog remains a key strength. 12-month backlog was up 13% from the prior year, while the multiyear backlog exceeded $30 billion, up 38%."

**Numbers:** 13%, $30 billion, 38%

### 3. freight_segment_backlog

**Claim:** Wabtec's Freight segment's 12-month backlog was up 10.1%, while the multiyear backlog of $25.18 billion was up 41.0%.

**Evidence (transcript):** "Finally, the Freight segment's 12-month backlog was $6.68 billion. Our 12-month backlog was up 10.1%, while the multiyear backlog of $25.18 billion was up 41.0%."

**Numbers:** 6.68, 10.1%, 25.18, 41.0%

### 4. transit_segment_growth

**Claim:** Wabtec's Transit segment sales were up 17.8% to $835 million, with the acquisition of Dellner contributing to this growth.

**Evidence (transcript):** "Transit segment sales were up 17.8% at $835 million. When adjusting for foreign currency Transit sales were up 11.0%. The acquisition of Dellner added a partial quarter of revenue, adding approximately 5.8 percentage points of sales growth."

**Numbers:** 17.8%, $835 million, 11.0%, 5.8

### 5. acquisition_synergies

**Claim:** Wabtec reports that the acquisitions of Inspection Technologies, Frauscher, and Dellner are performing ahead of plan, with synergy run rate savings expected to scale meaningfully over the coming years.

**Evidence (transcript):** "With regard to our most recent acquisition of Inspection Technologies, Frauscher and Dellner, these businesses are off to a great start with Wabtec. While still early, they are delivering ahead of our acquisition plan. On integration of these acquisitions, we continue to execute very well. Currently, our teams are making solid progress where our integration plan is firmly in place and early synergy realization is also tracking as expected. We're already seeing early benefits and expect synergy run rate savings to scale meaningfully over the coming years."

**Numbers:** —

### 6. 2026_railcar_demand

**Claim:** Wabtec notes that demand for new railcars in North America is expected to be approximately 24,000 cars for 2026, which is down 22% from 2025.

**Evidence (transcript):** "Looking at the North American railcar build, demand for new railcars is down compared to the prior year and is projected to be approximately 24,000 cars for 2026, which is down 22% from 2025."

**Numbers:** 24,000, 22%, 2025


---

*Data source: FMP (live query, 2026-05-05), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
